UPDATES:

It's a trap

SHIPSHEWANA — Fifteen years of trapping animals has taught Todd Lang that trapping is an effective and humane way of catching animals. Not everyone shares the Indiana Conservation Officer’s opinion though. “There are a lot of misconceptions with the use of traps and one of... more...

Boocoo Auctions
View race results and purchase photos, mugs, t-shirts, and other personalized merchandise.
KPC Media offers web design and hosting services at affordable rates. Click for more info.
The deadline for 2010 Health Care Heroes nominations is July 30th at 5:00pm. Click to apply now!
The deadline for 2010 Innovation Award nominations is August 20th at 5:00pm. Click to apply now!
AP Videos »
Strange Headlines »
Some blood pressure medicines may cut dementia risk PDF Print E-mail
By Dr. Terry Gaff
Sunday, 31 January 2010 00:00

The other day, I was thinking. Today, I am also thinking. In the future, I hope to continue thinking.

My goal to continue thinking clearly is one of the reasons I am very interested in studies about how to minimize the development and/or progression of Alzheimer’s disease and other dementias, which rob their victims of memories and thinking abilities.

This month, a group of researchers from Boston University School of Medicine published a study in the British Medical Journal telling us that there may be a way to decrease Alzheimer’s disease.

They found that angiotensin receptor blockers (ARBs), a particular class of blood pressure control medicines, are associated with a striking decrease in the occurrence and progression of dementia.

Using data from the Decision Support System Database of the U.S. Department of Veterans Affairs (with information on more than five million people) they looked at records from patients who used ARBs, and compared them with people who had a similar health status, but were taking different medications.

They found that patients taking ARBs had up to a 50 percent lower chance of getting Alzheimer’s disease or dementia. Patients taking two forms of medications that affect the angiotensin system, ARBs and Angiotensin Converting Enzyme (ACE) inhibitors, had a 55 percent lower risk of dementia.

People who were already suffering from Alzheimer’s disease or dementia had up to a 67 percent lower chance of being admitted to nursing homes or dying if they were taking both ARBs and ACE inhibitors.

Patients who appeared to benefit particularly well from use of ARBs were those who had experienced strokes before or during the course of their illness.

It is suggested that those who already have dementia might use ARBs to delay deterioration of brain function and help keep patients out of nursing homes. It appears that ARBs are more effective than other blood pressure and cardiovascular medicines for preventing Alzheimer’s disease or dementia.

Although the researchers are unsure why ARBs might be so beneficial, they believe one possibility suggested by prior studies on animal models is that ARBs help prevent nerve cell injury from blood vessel damage or help promote nerve cell recovery after blood vessel damage. The authors also speculate that ARBs might help protect the blood vessels in the brain against damage related to heart disease.

The ARB medicines include the following: losartan (Cozaar), candesartan (Atacand), valsartan (Diovan), irbesartan (Avapro), telmisartan (Micardis), eprosartan (Teveten), and olmesartan (Benicar).

In addition to their effect of dementia and their original use controlling high blood pressure, the ARBs (particularly candesartan) have been used for the treatment of heart failure in people who cannot tolerate ACE inhibitor therapy. Irbesartan and losartan have shown benefit in patients with both high blood pressure and type II diabetes, and may delay the progression of kidney damage due to diabetes. Candesartan is even used experimentally to try to prevent migraine headaches.

Along with all the good effects, there are some common side effects. These include dizziness, headache, and/or elevated potassium levels. Infrequently, they might cause blood pressure to drop too low when standing, rash, diarrhea, stomach upset, abnormal liver function, muscle cramps or pains, back pain, insomnia, anemia, kidney impairment, sore throat, and/or nasal congestion. The dry cough and/or facial or tongue swelling sometimes associated with ACE inhibitor therapy may rarely occur with ARBs.

Nobody is sure whether or not there is a slight increase in the risk of heart attack due to ARB use. Some studies have demonstrated that ARBs can increase that risk while other studies have found that they do not. Further investigations are underway.

For myself, I will continue to do everything I can to avoid needing to take blood pressure medicine by using exercise and salt avoidance as well as weight and stress control. However, the chance to avoid or delay dementia has moved ARBs much higher on my list of possible medicines if my blood pressure becomes too high.

add usual tagline please

Comments
Add New Search
Chris  - RAMIPRIL   |124.124.51.xxx |2010-07-30 00:04:33
Ramipril is used to treat high blood pressure (hypertension) and congestive
heart failure. It belongs to a group of drugs called ACE inhibitors, which
reduces the chances of heart attack and stroke, improves survival after a heart
attack, and prevents kidney failure due to high blood pressure and diabetes.

http://www.internationaldrugmart.com/ramipril.sht ml
Anonymous  - blood pressure meds   |75.139.239.xxx |2010-04-17 01:43:54
good info
Anonymous   |152.133.7.xxx |2010-04-13 20:35:04
good reading
Write comment
Name:
Email:
 
Title:
 
Please input the anti-spam code that you can read in the image.

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Like it? Share it!

Add to: JBookmarks Add to: Facebook Add to: Digg Add to: Del.icoi.us Add to: Reddit Add to: StumbleUpon Add to: Slashdot Add to: Yahoo Add to: Newsvine Add to: Google Information